## SLAB: Silicon Laboratories Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 8.2% in mid entry zone (4.0-10.0%), top 6% cross-sectional ranking. Short-term MRS_5 (5.8%) confirms momentum alignment. Strong momentum (+7.7% 5-day acceleration). Outperforming sector by 8.6%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($128.36)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($0.02M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- FMR, LLC: 15.0% (+0.8%)
- Blackrock Inc.: 13.7% (+2.5%)
- Vanguard Group Inc: 11.8% (+1.9%)
- State Street Corpora: 4.7% (+2.4%)
- Macquarie Group Limi: 3.0% (-8.6%)

### Key Risks

1. Valuation stretched: PEG 3.0x requires aggressive growth execution.
2. Elevated short interest (9.4%): bears positioning against stock.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +7.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.03 signals overvaluation risk, limited margin of safety. Forward P/E 51.2x attractive for 197% earnings growth. Balance sheet: strong liquidity (4.5x), low leverage (D/E 0.17). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.4B |
| Beta | 1.56 |
| 52W Range | $82.82 - $160.00 |
| Short Interest | 9.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.03 |
| Forward P/E | 51.2 |
| Current P/E | 152.0 |
| YoY Growth | 197.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 0.5% to 8.2% (+7.7% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 93rd percentile. MRS_5 at 5.8% confirms short-term momentum alignment. AM_20 at 10.2% shows strong absolute momentum above own 20MA. Outperforming sector by 8.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.83), confirming momentum. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 8.23% (CS: 94) | Strong |
| RSI_14 | 65.5 | Neutral |
| MACD Histogram | 1.83 | Bullish |
| vs SMA20 | 1.102x | Above |
| vs SMA50 | 1.063x | Above |
| vs SMA200 | 1.071x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $137.68
- **Stop Loss:** $128.36 (6.8% risk)
- **Target:** $151.66 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 101
- **Position Value:** $13,905.68
- **Portfolio %:** 13.91%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-03 (Est: $0.55)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.31 | $0.32 | +4.2% |
| 2025Q2 | $0.09 | $0.11 | +18.7% |
| 2025Q1 | $-0.09 | $-0.08 | +10.9% |
| 2024Q4 | $-0.11 | $-0.11 | -1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*